InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- MDR September 2017 Quarterly Report & Appendix 4C 19 Oct 2017 2:17PM $0.036 $0.022 fallen by 38.89%
- Appendix 3B - New Share Issue 19 Oct 2017 12:56PM $0.036 $0.022 fallen by 38.89%
- Appendix 3B - Founder Performance Shares and Read Rights 19 Oct 2017 12:55PM $0.036 $0.022 fallen by 38.89%
- Notice of Annual General Meeting 11 Oct 2017 11:14AM $0.037 $0.022 fallen by 40.54%
- MDR Investor Presentation - September 2017 13 Sep 2017 9:57AM $0.037 $0.022 fallen by 40.54%
- MedAdvisor to Advance Global Expansion Strategy 12 Sep 2017 12:16PM $0.035 $0.022 fallen by 37.14%
- MDR Appendix 4G Key Corporate Governance Disclosures 30 Aug 2017 12:52PM $0.031 $0.022 fallen by 29.03%
- ASX Listing Rule 4.10.19 Statement 30 Aug 2017 12:45PM $0.031 $0.022 fallen by 29.03%
- MDR Final FY17 Results & Appendix 4E 30 Aug 2017 12:44PM $0.031 $0.022 fallen by 29.03%
- MDR Jun-17 Quarterly Report & 4C 17 Jul 2017 12:46AM $0.029 $0.022 fallen by 24.14%
- Appendix 3Y 28 Jun 2017 12:44AM $0.031 $0.022 fallen by 29.03%
- MedAdvisor Appoints Chief Technology Officer 13 Jun 2017 11:36AM $0.029 $0.022 fallen by 24.14%
- MedAdvisor Partners with Discount Drug Stores 31 May 2017 10:08AM $0.030 $0.022 fallen by 26.67%
- MedAdvisor Partners with US Company iHealth Labs 29 May 2017 1:17PM $0.030 $0.022 fallen by 26.67%
- Appendix 3B 24 May 2017 2:01PM $0.029 $0.022 fallen by 24.14%
- MDR Mar-17 Quarterly Report and 4C 11 Apr 2017 11:39AM $0.032 $0.022 fallen by 31.25%
- Investor Presentation - March 2017 20 Mar 2017 9:41AM $0.034 $0.022 fallen by 35.29%
- Change in Director's Interest Notice - Xenos 16 Mar 2017 9:04AM $0.034 $0.022 fallen by 35.29%
- Change in Director's Interest Notice - Bennetto 16 Mar 2017 9:04AM $0.034 $0.022 fallen by 35.29%
- Vesting of CEO Performance Rights 6 Mar 2017 8:28AM $0.035 $0.022 fallen by 37.14%
- Change of Director's Interest Notice 28 Feb 2017 8:24AM $0.035 $0.022 fallen by 37.14%
- Change of Director's Interest Notice 27 Feb 2017 3:16PM $0.035 $0.022 fallen by 37.14%
- MDR - Wholesale investor presentation - Sydney 21 Feb 2017 21 Feb 2017 2:44PM $0.035 $0.022 fallen by 37.14%
- Completion of OzDocsOnline Acquisition by MedAdvisor 20 Feb 2017 3:45PM $0.034 $0.022 fallen by 35.29%
- MedAdvisor Appendix 4D and Financial Report - Dec16 17 Feb 2017 11:58AM $0.034 $0.022 fallen by 35.29%

651 - 675 of 761 results

Page 27 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.